NEW
YORK, Nov. 4, 2024 /PRNewswire/ -- Baird Medical
(Nasdaq: BDMD), a leader in minimally invasive microwave ablation
(MWA) technology, proudly participated in the 2024 American Thyroid
Association (ATA) Annual Meeting. This year's event marked a
milestone for Baird Medical, as it attracted significant interest
from physicians and researchers worldwide, including attendees from
the U.S., Europe, and South America.
The company's booth was a highlight of the exhibition floor,
drawing in a constant stream of visitors eager to learn about
Baird's latest innovations. Attendees engaged with the company's
representatives, explored demonstrations of MWA technology, and
participated in insightful discussions about the clinical benefits
and advancements in thyroid treatments.
A major highlight of Baird Medical's Expo Theater session,
expertly led by Dr. Helmi Khadra
from Houston Methodist Hospital, was an impactful presentation by
Dr. Emad Kandil, Professor at
Tulane University School of Medicine.
Dr. Kandil's presentation featured valuable clinical data,
highlighting a compelling patient case where MWA succeeded
following an RFA failure. He also offered a comparative analysis of
MWA and RFA, along with practical recommendations for clinical
application. "MWA of thyroid nodules is a novel, safe, and
effective method for treating appropriately selected benign and
malignant thyroid nodules in adults and pediatric populations. It
can provide advantages compared to other thermal ablation
techniques," stated Dr. Kandil. The session concluded with a
dynamic Q&A, fostering thought-provoking dialogue and
underscoring the medical community's growing interest in MWA.
Building on Dr. Kandil's clinical insights, Dr. Feng Han expanded the discussion by focusing on
advanced procedural techniques and energy management. An expert
from Sun Yat-sen University Cancer
Center with extensive experience performing thousands of MWA
procedures, Dr. Han shared key strategies for optimizing patient
outcomes through refined MWA practices. His presentation provided
attendees with a unique perspective on enhancing treatment
precision and efficiency, encouraging meaningful discussions with
global physicians eager to integrate these techniques into their
practice.
The Expo Theater session concluded with hands-on demonstrations
where medical professionals interacted directly with Baird's MWA
technology and posed detailed questions about its applications.
Baird Medical's participation at the ATA meeting underscored its
dedication to contributing to advancements in thyroid treatment,
highlighting its ongoing efforts to support the medical community
and foster valuable connections on a global scale. The company
remains focused on continuing these efforts and exploring
opportunities to advance its role in innovative thyroid care
solutions.
About Baird Medical
Baird Medical is a leading provider of minimally invasive microwave
ablation (MWA) technology, offering advanced treatment solutions
for conditions such as thyroid nodules, breast disease, uterine
fibroids, and liver cancer. A publicly traded company on NASDAQ,
Baird Medical is dedicated to enhancing patient care through
precision, efficiency, and safety in its innovative medical
devices. For more information, please visit
https://bairdmed.com/
View original content to download
multimedia:https://www.prnewswire.com/news-releases/baird-medicals-advanced-microwave-ablation-solutions-captivate-attendees-at-the-2024-ata-meeting-302294994.html
SOURCE Baird Medical LLC